Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
BMY
Bristol-Myers Squibb
$45.45
Login to see Bristol-Myers Squibb (BMY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Trading below its fair value
Earnings are forecast to grow
Investors confidence is positive
Chart
$47.23 (-3.77%)
$47.44 (-4.19%)
$44.33 (+2.53%)
$53.22 (-14.60%)
BMY has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
BMY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
Investors confidence is positive
Future
Future
Trading below its fair value
Earnings are forecast to grow
BMY Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BMY Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayBMY Earnings
The TTM reflects 12-month period, providing review of BMY financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is BMY current stock price?
What are BMY stock strengths?
What risks are associated with BMY stock?
When is BMY next earnings report?
What is BMY market cap and volume?
What is BMY's current Stock IQ?
Should I buy BMY stock right now?
Is BMY a Strong Buy right now?
What does a 'Strong Buy' rating mean for BMY?
What does a 'Strong Sell' rating mean for BMY?
What factors influence BMY's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
BMY
Bristol-Myers Squibb
Current Price
$45.45
Stock Insights
Strengths
Trading below its fair value
Earnings are forecast to grow
Investors confidence is positive
Login to unlock Bristol-Myers Squibb (BMY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$47.23 (-3.77%)
$47.44 (-4.19%)
$44.33 (+2.53%)
$53.22 (-14.60%)
BMY Analysts Opinion
BMY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
Investors confidence is positive
Future
Future
Trading below its fair value
Earnings are forecast to grow
BMY Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BMY Street view is extremely bullish and have positive views on the near-term outlook
BMY has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayBMY Earnings
The TTM data reflects the most recent 12-month period, providing overview of BMY financial performance.
BMY Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
BMY Latest Analysis
Bristol Myers Squibb Says FDA Grants Fast Track Status To BMS-986446 For Alzheimers Treatment . (RTTNews) - Bristol Myers Squibb (BMY) announced Wednesday that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to BMS-986446 a potential best-in-class anti-microtubule binding region-tau (anti-MTBR-tau) antibody currently in Phase 2 development fo
Wed Oct 1, 2025
Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities. Bristol-Myers Squibb Company (NYSE:BMY) is one of the best conservative stocks to buy now. On September 23 at the Bernstein Insights: Healthcare Leaders and Disruptors the company emphasized its leadership in cell therapy. The remarks come on the company treating 13000 patients with cell therapy while leveraging extensive clinical data. Likewise it is currently working [….]
Tue Sep 30, 2025
How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets. Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best Recession Proof Dividend Stocks to Buy. Bristol-Myers Squibb Company (NYSE:BMY) is an American multinational pharmaceutical company. It concentrates primarily on branded pharmaceuticals a sector known for high entry barriers and strong profitability. Developing breakthrough drugs requires billions in investment and years of research with relat
Mon Sep 29, 2025
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It. Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.
Mon Sep 29, 2025
Bristol Myers Squibb Announces New BMS Patient Connect Platform For Sotyktu At Over 80% Discount . (RTTNews) - Bristol Myers Squibb (BMY) on Thursday announced an expansion of its direct-to-patient program allowing eligible United States patients to access Sotyktu at significantly reduced prices.
Thu Sep 25, 2025
Bristol-Myers Squibb Company (BMY) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum Transcript.
Tue Sep 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings